Document is current
Any future updates will be listed below
-
Authors
Liu, Zaizhou
Chen, Kaige
Dai, Jun
Xu, Peng
Sun, Wei
Liu, Wanlin
Zhao, Zhixin
Bennett, Steven P.
Li, Peifeng
Ma, Tiancheng
Lin, Yuqi
Kawakami, Akinori
Yu, Jing https://orcid.org/0000-0001-7371-4512
Wang, Fei
Wang, Chunxi
Li, Miao
Chase, Peter
Hodder, Peter
Spicer, Timothy P.
Scampavia, Louis
Cao, Chunyang https://orcid.org/0000-0001-7865-8249
Pan, Lifeng https://orcid.org/0000-0002-9229-6288
Dong, Jiajia
Chen, Yong
Yu, Biao
Guo, Min
Fang, Pengfei https://orcid.org/0000-0002-3448-5494
Fisher, David E.
Wang, Jing https://orcid.org/0000-0002-7566-1212
- License Information
-
More Information
Article History
Received: 16 August 2021
Accepted: 17 October 2022
First Online: 2 January 2023
Competing interests
: Dr. D.E.F. has a financial interest in Soltego Inc., a company developing SIK inhibitors for topical skin darkening treatments that might be used for a broad set of human applications. Dr. D.E.F. interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their competing interests policies.
